Information supplied by Google generative AI
The AMA is continuing its state-by-state critique of the medicinal cannabis industry, citing concerns about “distressing incidents of patient harm” in South Australia, specifically due to “inappropriate prescribing practices”.
Here’s a more detailed breakdown:
-
AMA’s Concerns:The Australian Medical Association (AMA) has publicly expressed concerns about the medicinal cannabis industry, claiming it is aware of “distressing incidents of patient harm”.
-
Focus on South Australia:The AMA’s criticism is specifically focused on South Australia, where they claim to have identified “inappropriate prescribing practices”.
-
“Inappropriate Prescribing Practices”:The AMA has not elaborated on what specific prescribing practices they consider inappropriate.
-
State-by-State Approach:The AMA’s criticism appears to be a state-by-state approach, with concerns being raised in South Australia, and potentially other states in the future.
-
Cannabiz Article:An article on Cannabiz.com.au reports that the AMA is renewing its attack on the industry, with South Australia now raising concerns.
